Quantcast
Tag archive for ‘acute bacterial skin and skin structure infections’
By Guest Author On Saturday, February 4th, 2017
0 Comments

Wondering how to care for your skin in the best ways possible?

The skin and skin care products are among the things that you cannot overlook. The skin being literally the first thing that one sees upon looking at you should be in its best condition always. There are one too More...

By The Dispatch On Monday, March 31st, 2014
2 Comments

Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee

PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...

By The Dispatch On Monday, December 30th, 2013
0 Comments

FDA accepts Cubist’s NDA for the investigational antibiotic tedizolid to treat MRSA infections

PRESS RELEASE  Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid More...

By Robert On Monday, November 5th, 2012
0 Comments

Antibiotic candidate, dalbavancin, designated as a Qualified Infectious Disease Product by the FDA

The intravenous antibiotic product candidate, dalbavancin,  has been designated as a Qualified Infectious Disease Product (QIDP) by the Food and Drug Administration (FDA), making it eligible for fast-track status, More...


Recent Posts


DISPATCH BLOGS

Splash Page logo 300x146 Today in History